DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+19.39%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$140M
AUM Growth
+$140M
(+19%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
83
New
9
Increased
22
Reduced
17
Closed
8
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$3.4M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.15M |
| 3 |
Sangamo Therapeutics
SGMO
|
$1.98M |
| 4 |
Minerva Neurosciences
NERV
|
$1.55M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$1.38M |
Top Sells
| 1 |
AtriCure
ATRC
|
$2.98M |
| 2 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$1.75M |
| 3 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$747K |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$398K |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$369K |
Sector Composition
| 1 | Healthcare | 80.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $24.3M | 17.37% | 303,621 +2,899 | +1% | +$232K |
|
|
2
AtriCure
ATRC
$1.84B
| $9.32M | 6.65% | 384,145 -122,801 | -24% | -$2.98M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $5.63M | 4.02% | 637,700 +385,126 | +152% | +$3.4M |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.61M | 4% | 106,770 +60,000 | +128% | +$3.15M |
|
|
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
| $5.42M | 3.87% | 216,119 | – | – |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $4.16M | 2.96% | 82,000 -500 | -0.6% | -$25.3K |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.29M | 2.35% | 591,128 +50,000 | +9% | +$278K |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.29M | 2.35% | 73,036 -8,195 | -10% | -$369K |
|
9
Insulet
PODD
$23.9B
| $3.26M | 2.32% | 63,484 | – | – |
|
10
Galapagos
GLPG
$2.07B
| $2.95M | 2.11% | 38,609 +3,250 | +9% | +$249K |
|
11
iShares Biotechnology ETF
IBB
$5.6B
| $2.7M | 1.93% | 8,700 | – | – |
|
|
ALDR
12
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.53M | 1.81% | 221,013 | – | – |
|
|
BEAT
13
DELISTED
BioTelemetry, Inc.
BEAT
| $2.51M | 1.79% | 75,000 | – | – |
|
14
Neurocrine Biosciences
NBIX
$13.8B
| $2.51M | 1.79% | 54,508 -4,000 | -7% | -$184K |
|
|
15
Minerva Neurosciences
NERV
$16.5M
| $2.45M | 1.74% | 276,317 +175,000 | +173% | +$1.55M |
|
|
RDUS
16
DELISTED
Radius Health, Inc.
RDUS
| $2.41M | 1.72% | 53,309 +4,500 | +9% | +$204K |
|
|
VIRX
17
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.3M | 1.64% | 850,328 -17,201 | -2% | -$46.4K |
|
|
DERM
18
DELISTED
Dermira, Inc.
DERM
| $2.2M | 1.57% | 75,500 +47,500 | +170% | +$1.38M |
|
|
AGTC
19
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.15M | 1.53% | 421,000 +10,000 | +2% | +$51K |
|
|
SPNC
20
DELISTED
Spectranetics Corp
SPNC
| $2.15M | 1.53% | 55,896 -9,600 | -15% | -$369K |
|
21
MacroGenics
MGNX
$112M
| $2.09M | 1.49% | 119,200 | – | – |
|
|
22
Sangamo Therapeutics
SGMO
$157M
| $1.98M | 1.41% | +225,000 | New | +$1.98M |
|
|
CLLS
23
Cellectis
CLLS
$258M
| $1.97M | 1.41% | 76,404 | – | – |
|
24
Akebia Therapeutics
AKBA
$833M
| $1.95M | 1.39% | 135,738 +65,283 | +93% | +$938K |
|
25
Ardelyx
ARDX
$1.53B
| $1.9M | 1.36% | 373,409 +151,671 | +68% | +$773K |
|